Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 6/20 | 0.62 |
| ▸ | ESR2 | Q92731 | 5/20 | 0.62 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.62 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.62 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.56 |
| ▸ | TAAR1 | Q96RJ0 | 5/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | PGR | P06401 | 1/20 | 0.48 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.48 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.48 |
| ▸ | AR | P10275 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2032476 | 1.00 | ESR1 (0.62) | ESR1ESR2PDCD1CD274ADRB2 | |
| SCHEMBL2037513 | 1.00 | ESR1 (0.62) | ESR1ESR2PDCD1CD274ADRB2 | |
| Bromide SCHEMBL23672238 | 0.97 | ESR1 (0.59) | ESR1ESR2PDCD1CD274ADRB2 | |
| Hydrochloric Acid SCHEMBL3178913 | 0.97 | ESR1 (0.59) | ESR1ESR2PDCD1CD274ADRB2 | |
| Bromide SCHEMBL15901678 | 0.97 | ESR1 (0.59) | ESR1ESR2PDCD1CD274ADRB2 | |
| Bromide SCHEMBL4909882 | 0.97 | ESR1 (0.59) | ESR1ESR2PDCD1CD274ADRB2 | |
| Hydrochloric Acid SCHEMBL14830851 | 0.97 | ESR1 (0.59) | ESR1ESR2PDCD1CD274ADRB2 | |
| Iodide SCHEMBL29068279 | 0.97 | ESR1 (0.59) | ESR1ESR2PDCD1CD274ADRB2 | |
| Hydrochloric Acid SCHEMBL8702706 | 0.97 | ESR1 (0.59) | ESR1ESR2PDCD1CD274ADRB2 | |
| SCHEMBL18664397 | 0.93 | ESR1 (0.54) | ESR1ESR2PDCD1CD274ADRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 737 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122054801-A | Solar cell, preparation method thereof, photovoltaic module, power utilization device and power generation device | 宁德时代新能源科技股份有限公司 | 2026-05-15 | — | — | CN | claimed |
| CN-120154011-A | Chemical pesticide composition and preparation method thereof | 潍坊华诺生物科技有限公司 | 2025-06-17 | — | — | CN | claimed |
| CN-120081881-A | Glutamic acid derivative, preparation method thereof and application thereof in rhythm gene regulation and antioxidation | 水羊化妆品制造有限公司 | 2025-06-03 | — | — | CN | claimed |
| CN-119663650-B | Production process of antistatic nylon fabric | 安徽金弘润新材料科技有限公司 | 2025-05-13 | — | — | CN | claimed |
| CN-119663650-A | Production process of antistatic nylon fabric | 安徽金弘润新材料科技有限公司 | 2025-03-21 | — | — | CN | claimed |
| CN-119587585-A | Acellular umbilical cord extract and preparation method and application thereof | 广州友瀚生物科技有限公司 | 2025-03-11 | — | — | CN | claimed |
| CN-119465653-A | Antistatic and antibacterial polyester fabric and preparation method and application thereof | 扬州纪元纺织有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-117945939-B | Bio-based self-assembled amide nucleating agent, and preparation method and application thereof | 广东工业大学 | 2025-01-28 | — | — | CN | claimed |
| CN-119350815-A | PCR-PET polyester film with excellent mechanical property and thermal stability and preparation method thereof | 四川东方绝缘材料股份有限公司 | 2025-01-24 | — | — | CN | claimed |
| CN-119331550-A | Low-dielectric chip mounting adhesive film composition and adhesive film | 北京序轮科技有限公司 | 2025-01-21 | — | — | CN | claimed |
| US-20050020659-A1 | Substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonists | ELAN PHARMACEUTICALS, INC. | 2005-01-27 | — | — | US | claimed |
| WO-1996019433-A1 | PROCESS FOR PREPARING ACETOXYSTYRENE | HOECHST CELANESE CORPORATION (US) | 1996-06-27 | — | — | WO | claimed |
| WO-1996019429-A1 | PROCESS FOR PREPARING 4-HYDROXYSTYRENE | HOECHST CELANESE CORPORATION (US) | 1996-06-27 | — | — | WO | claimed |
| WO-1996019506-A1 | PROCESS FOR PREPARING POLY(4-HYDROXYSTYRENE) | HOECHST CELANESE CORPORATION (US) | 1996-06-27 | — | — | WO | claimed |
| US-5493062-A | Process for preparing 4-hydroxystyrene | HOECHST CELANESE CORPORATION (US) | 1996-02-20 | — | — | US | claimed |
| US-5463108-A | Acetylation of 4-hydroxystyrene in the presence of an acetylating agent | HOECHST CELANESE CORPORATION (US) | 1995-10-31 | — | — | US | claimed |
| US-5463141-A | Process for preparing poly(4-hydroxystyrene) | HOECHST CLANESE CORPORATION (US) | 1995-10-31 | — | — | US | claimed |
| US-5252707-A | Controlling metabolic procersses | MITSUI TOATSU CHEMICALS INCORPORATED (JP) | 1993-10-12 | — | — | US | claimed |
| US-5252628-A | Blends with melanin pigments | LIONS EYE INSTITUTE OF WESTERN AUSTRALIA, INC. | 1993-10-12 | — | — | US | claimed |
| EP-0445299-A1 | INOSITOL DERIVATIVE AND PRODUCTION THEREOF | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1991-09-11 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050020659-A1 | Substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonists | BDKRB1, BDKRB2, BRS3 | ESR1 1506/4885ESR2 1166/4885PDCD1 2170/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.